Circulating MicroRNAs Associated with Changes in the Placenta and Their Possible Role in the Fetus During Gestational Diabetes Mellitus: A Review

MicroRNAs (miRs) are epigenetic regulators of several metabolic diseases, including gestational diabetes mellitus (GDM). Objectives: Following a systematic review, we propose a pattern of key circulating miRs associated with placental changes and their potential role in the fetus. Methods: A systema...

Full description

Saved in:
Bibliographic Details
Main Authors: Ninna Leslie Trejo-Gonzalez, Martin Palomar-Morales, Luis Arturo Baiza-Gutman, Guadalupe Diaz-Rosas, Clara Ortega-Camarillo, Alejandra Contreras-Ramos
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/15/6/367
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839653321559769088
author Ninna Leslie Trejo-Gonzalez
Martin Palomar-Morales
Luis Arturo Baiza-Gutman
Guadalupe Diaz-Rosas
Clara Ortega-Camarillo
Alejandra Contreras-Ramos
author_facet Ninna Leslie Trejo-Gonzalez
Martin Palomar-Morales
Luis Arturo Baiza-Gutman
Guadalupe Diaz-Rosas
Clara Ortega-Camarillo
Alejandra Contreras-Ramos
author_sort Ninna Leslie Trejo-Gonzalez
collection DOAJ
description MicroRNAs (miRs) are epigenetic regulators of several metabolic diseases, including gestational diabetes mellitus (GDM). Objectives: Following a systematic review, we propose a pattern of key circulating miRs associated with placental changes and their potential role in the fetus. Methods: A systematic investigation of studies published between January 2011 and July 2024 was conducted in the PubMed, ScienceDirect, Trip Database, and Wiley databases. A total of 90 articles were analyzed. Results: Two hundred twenty-six circulating microRNAs were identified in women with GDM, and fifty miRs were validated by PCR, with miRs-16-5p, -29a-5p, and -195-5p being the most frequently reported. Interestingly, miR-16-5p was also expressed in the placenta but not in umbilical cord blood or amniotic fluid. Conversely, miR-126-3p was expressed in circulation, the placenta, umbilical cord blood, and amniotic fluid. Several reports describe high expression levels of miR-518d in maternal circulation, umbilical cord blood, and placenta. Controversial results regarding the expression of miR-29a-3p, -137, and -148a-3p were identified when comparing umbilical cord blood and the placenta. Conclusions: In silico analyses suggest that the miR-29 family, as well as miRs-16-5p, -126-3p, -195-5p, and -518b, may be involved in alterations in the heart, brain, and kidneys in the embryo when exposed to a hyperglycemic environment.
format Article
id doaj-art-1b33c15a3a28441bb9bf0dd5dbce9ad6
institution Matheson Library
issn 2218-1989
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj-art-1b33c15a3a28441bb9bf0dd5dbce9ad62025-06-25T14:10:24ZengMDPI AGMetabolites2218-19892025-06-0115636710.3390/metabo15060367Circulating MicroRNAs Associated with Changes in the Placenta and Their Possible Role in the Fetus During Gestational Diabetes Mellitus: A ReviewNinna Leslie Trejo-Gonzalez0Martin Palomar-Morales1Luis Arturo Baiza-Gutman2Guadalupe Diaz-Rosas3Clara Ortega-Camarillo4Alejandra Contreras-Ramos5Postgraduate in Biological Sciences, National Autonomous University of Mexico, Mexico City C.P. 04510, MexicoDepartment of Biology, Faculty of Higher Studies Iztacala, National Autonomous University of Mexico, Mexico City C.P. 54090, MexicoLaboratory of Developmental Biology, Morphology and Function Unit, Faculty of Higher Studies Iztacala, National Autonomous University of Mexico, Mexico City C.P. 54090, MexicoMolecular Biology Research Laboratory, Children’s Hospital of Mexico Federico Gomez (HIMFG), Mexico City C.P. 06720, MexicoMedical Research Unit in Biochemistry, Specialties Hospital, National Medical Center SXXI, Instituto Mexicano del Seguro Social, Mexico City C.P. 06720, MexicoMolecular Biology Research Laboratory, Children’s Hospital of Mexico Federico Gomez (HIMFG), Mexico City C.P. 06720, MexicoMicroRNAs (miRs) are epigenetic regulators of several metabolic diseases, including gestational diabetes mellitus (GDM). Objectives: Following a systematic review, we propose a pattern of key circulating miRs associated with placental changes and their potential role in the fetus. Methods: A systematic investigation of studies published between January 2011 and July 2024 was conducted in the PubMed, ScienceDirect, Trip Database, and Wiley databases. A total of 90 articles were analyzed. Results: Two hundred twenty-six circulating microRNAs were identified in women with GDM, and fifty miRs were validated by PCR, with miRs-16-5p, -29a-5p, and -195-5p being the most frequently reported. Interestingly, miR-16-5p was also expressed in the placenta but not in umbilical cord blood or amniotic fluid. Conversely, miR-126-3p was expressed in circulation, the placenta, umbilical cord blood, and amniotic fluid. Several reports describe high expression levels of miR-518d in maternal circulation, umbilical cord blood, and placenta. Controversial results regarding the expression of miR-29a-3p, -137, and -148a-3p were identified when comparing umbilical cord blood and the placenta. Conclusions: In silico analyses suggest that the miR-29 family, as well as miRs-16-5p, -126-3p, -195-5p, and -518b, may be involved in alterations in the heart, brain, and kidneys in the embryo when exposed to a hyperglycemic environment.https://www.mdpi.com/2218-1989/15/6/367gestational diabetesmaternal circulationmiRNAsplacentaamniotic fluidumbilical cord blood
spellingShingle Ninna Leslie Trejo-Gonzalez
Martin Palomar-Morales
Luis Arturo Baiza-Gutman
Guadalupe Diaz-Rosas
Clara Ortega-Camarillo
Alejandra Contreras-Ramos
Circulating MicroRNAs Associated with Changes in the Placenta and Their Possible Role in the Fetus During Gestational Diabetes Mellitus: A Review
Metabolites
gestational diabetes
maternal circulation
miRNAs
placenta
amniotic fluid
umbilical cord blood
title Circulating MicroRNAs Associated with Changes in the Placenta and Their Possible Role in the Fetus During Gestational Diabetes Mellitus: A Review
title_full Circulating MicroRNAs Associated with Changes in the Placenta and Their Possible Role in the Fetus During Gestational Diabetes Mellitus: A Review
title_fullStr Circulating MicroRNAs Associated with Changes in the Placenta and Their Possible Role in the Fetus During Gestational Diabetes Mellitus: A Review
title_full_unstemmed Circulating MicroRNAs Associated with Changes in the Placenta and Their Possible Role in the Fetus During Gestational Diabetes Mellitus: A Review
title_short Circulating MicroRNAs Associated with Changes in the Placenta and Their Possible Role in the Fetus During Gestational Diabetes Mellitus: A Review
title_sort circulating micrornas associated with changes in the placenta and their possible role in the fetus during gestational diabetes mellitus a review
topic gestational diabetes
maternal circulation
miRNAs
placenta
amniotic fluid
umbilical cord blood
url https://www.mdpi.com/2218-1989/15/6/367
work_keys_str_mv AT ninnaleslietrejogonzalez circulatingmicrornasassociatedwithchangesintheplacentaandtheirpossibleroleinthefetusduringgestationaldiabetesmellitusareview
AT martinpalomarmorales circulatingmicrornasassociatedwithchangesintheplacentaandtheirpossibleroleinthefetusduringgestationaldiabetesmellitusareview
AT luisarturobaizagutman circulatingmicrornasassociatedwithchangesintheplacentaandtheirpossibleroleinthefetusduringgestationaldiabetesmellitusareview
AT guadalupediazrosas circulatingmicrornasassociatedwithchangesintheplacentaandtheirpossibleroleinthefetusduringgestationaldiabetesmellitusareview
AT claraortegacamarillo circulatingmicrornasassociatedwithchangesintheplacentaandtheirpossibleroleinthefetusduringgestationaldiabetesmellitusareview
AT alejandracontrerasramos circulatingmicrornasassociatedwithchangesintheplacentaandtheirpossibleroleinthefetusduringgestationaldiabetesmellitusareview